* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Normal myocardial function in severe right ventricular volume
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Heart failure wikipedia , lookup
Myocardial infarction wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Am J Physiol Heart Circ Physiol 280: H11–H16, 2001. Normal myocardial function in severe right ventricular volume overload hypertrophy YUJI ISHIBASHI,1 JUDITH C. REMBERT,2 BLASE A. CARABELLO,1 SHINTARO NEMOTO,1 MASAYOSHI HAMAWAKI,1 MICHAEL R. ZILE,1 JOSEPH C. GREENFIELD, JR.,2 AND GEORGE COOPER IV1 1 Gazes Cardiac Research Institute, Medical University of South Carolina, and Department of Veterans Affairs Medical Center, Charleston, South Carolina 29403; and 2Cardiology Division, Department of Medicine, Duke University Medical Center and Department of Veterans Affairs Medical Center, Durham, North Carolina 27705 Ishibashi, Yuji, Judith C. Rembert, Blase A. Carabello, Shintaro Nemoto, Masayoshi Hamawaki, Michael R. Zile, Joseph C. Greenfield, Jr., and George Cooper, IV. Normal myocardial function in severe right ventricular volume overload hypertrophy. Am J Physiol Heart Circ Physiol 280: H11–H16, 2001.—Severe left ventricular volume overloading causes myocardial and cellular contractile dysfunction. Whether this is also true for severe right ventricular volume overloading was unknown. We therefore created severe tricuspid regurgitation percutaneously in seven dogs and then observed them for 3.5–4.0 yr. All five surviving operated dogs had severe tricuspid regurgitation and right heart failure, including massive ascites, but they did not have left heart failure. Right ventricular cardiocytes were isolated from these and from normal dogs, and sarcomere mechanics were assessed via laser diffraction. Right ventricular cardiocytes from the tricuspid regurgitation dogs were 20% longer than control cells, but neither the extent (0.171 ⫾ 0.005 m) nor the velocity (2.92 ⫾ 0.12 m/s) of sarcomere shortening differed from controls (0.179 ⫾ 0.005 m and 3.09 ⫾ 0.11 m/s, respectively). Thus, despite massive tricuspid regurgitation causing overt right heart failure, intrinsic right ventricular contractile function was normal. This finding for the severely volume-overloaded right ventricle stands in distinct contrast to our finding for the left ventricle severely volume overloaded by mitral regurgitation, wherein intrinsic contractile function is depressed. mitral regurgitation; cardiocyte contractile function PATHOLOGICAL VENTRICULAR VOLUME OVERLOADING is caused by a variety of structural and metabolic abnormalities. Experimental models of pathological left ventricular (LV) volume overloading have shown that, as in humans, if not initially lethal it may be tolerated for an extended period of time, but left heart failure develops eventually if a sustained volume overload is severe. In mitral regurgitation, this is based on muscle dysfunction at the level of the ventricle and of its constituent cardiocytes (29), which in turn appears to be caused by Address for reprint requests and other correspondence: G. Cooper, IV, Gazes Cardiac Research Institute, P.O. Box 250773, Medical Univ. of South Carolina, 114 Doughty St., Charleston, SC 29403 (E-mail: [email protected]). http://www.ajpheart.org myofibrillar lysis (29), abnormalities of the force-frequency relationship, and calcium metabolism (2, 18). Right ventricular (RV) volume overloading appears to be better tolerated than LV volume overloading. We have found, for instance, that experimental animals with severe RV volume overloading caused by atrial septal resection, which results in a ratio of pulmonary to systemic blood flow as great as 4:1, exhibit normal RV muscle function and energetics for at least 6 mo (8). Furthermore, humans with similarly severe RV volume overloading caused by atrial septal defects exhibit normal RV systolic function indefinitely if pulmonary hypertension with consequent RV pressure overloading does not supervene (16). However, because the geometry of the RV makes separation of loading conditions from intrinsic contractility difficult and because the calculations of wall stress often used to estimate RV loading are extremely complex and remain largely unvalidated, intrinsic RV contractility has been difficult to assess (20, 23). Over the past decade, we have shown that, for both normal and abnormal myocardium, the contractile function of isolated cardiocytes assessed in vitro mirrors the intrinsic contractile function in vivo of the ventricle from which the cardiocytes were isolated (15, 29). We therefore used this principle here to test the hypothesis that intrinsic contractile function is normal in long-term, severe RV volume overloading. METHODS Animal models. Mongrel dogs of random sex weighing 25–35 kg were the subjects of this study. For the creation of tricuspid regurgitation, anesthesia in dogs sedated with morphine was induced with thiopental sodium (15 ml iv). After intubation, we maintained anesthesia by inhalation of halothane (5% initially, followed by 0.2–0.5%). All procedures and the care of the dogs were in accordance with institutional guidelines, which meet or exceed those of the American Physiological Society and the American Association for AcThe costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. H11 Downloaded from http://ajpheart.physiology.org/ by 10.220.33.5 on May 12, 2017 Received 9 February 2000; accepted in final form 1 August 2000 H12 MYOCARDIAL FUNCTION IN TRICUSPID REGURGITATION Table 1. Hemodynamic profiles Table 2. Dimensions of RV cardiocytes Characteristics Control TR Ascites, peripheral edema Right atrial pressure (a wave), mmHg Right atrial pressure (v wave), mmHg RV systolic pressure, mmHg RV end-diastolic pressure, mmHg Aortic systolic pressure, mmHg ⫺ 4.5 ⫾ 0.3 3.6 ⫾ 0.4 26.7 ⫾ 1.8 4.1 ⫾ 0.7 117.7 ⫾ 5.3 ⫹ 4.1 ⫾ 0.8 17.8 ⫾ 2.5* 24.7 ⫾ 1.7 15.4 ⫾ 0.5* 113.3 ⫾ 4.2 Values are mean ⫾ SE; n ⫽ 7 control dogs and 5 tricuspid regurgitation (TR) dogs. a, peak a wave pressure; v, peak v wave pressure; RV, right ventricular. * P ⬍ 0.001 for a difference from control value by Student’s unpaired t-test. Fig. 1. Right ventriculography of a dog with tricuspid regurgitation. The contrast material was injected at a rate of 15 ml/s, and the images were taken in the left anterior oblique position. Left: heart at end diastole; right: heart at end systole. The short arrows indicate the right atrium, and the long arrows indicate the right ventricle (RV). Note the denser opacification of the right atrium than of the RV in left and incomplete ejection of contrast material from the right atrium in right. TR 156 ⫾ 3 34 ⫾ 1 187 ⫾ 4* 40 ⫾ 1* Values are mean ⫾ SE; n ⫽ 44 control dogs and 63 TR dogs. * P ⬍ 0.001 for a difference from control value by Student’s unpaired t-test. used before in evaluating our model of surgically created mitral regurgitation (3, 29). Cardiocyte isolation. Immediately after the in vivo evaluation of cardiac function by one subset of investigators, and after the dogs were more deeply anesthetized, another subset of investigators, who were not informed of the results of this evaluation, isolated and evaluated cardiocytes from these same RVs as follows. A right lateral thoracotomy was performed, the pericardium was excised, and the right coronary artery was isolated. The heart was removed and placed in cold, nominally calcium-free buffer of the following composition (in mM): 13.0 NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 NaH2PO4, 2.5 NaHCO3, 12.0 HEPES buffer, and 12.5 glucose; 6 mg/l insulin was also added. The right coronary artery was cannulated immediately, and perfusion with the same buffer was initiated. The RV free wall was removed from the rest of the heart, and the specimen was cleared of blood by brief perfusion with the same buffer warmed to 37°C and gassed with 100% O2. The method then used to dissociate cardiocytes from the canine RV was modified from that previously reported by us for the canine LV (29): perfusion was continued for 25 min at 37°C by recirculating the buffer, now supplemented with 155 U/ml type II collagenase and 10 M Ca2⫹; mean pressure (⬃90 mmHg) and pH (⬃7.40) were kept within the physiological range. Any undissociated tissue was discarded and that remaining was placed in a chamber containing the above buffer supplemented with 0.3 mM Ca2⫹, 2.5% bovine serum albumin, and 62 U/ml of the same collagenase used for perfusion. After mincing the tissue into small pieces with scissors, we gently agitated the tissue for 5 min at 37°C in the same buffer while gassing the tissue with 100% oxygen. Dissociated cardiocytes were harvested by passing the supernatant through a 210-m nylon mesh and collecting Downloaded from http://ajpheart.physiology.org/ by 10.220.33.5 on May 12, 2017 creditation of Laboratory Animal Care. Tricuspid regurgitation was created in seven dogs by a modification (1, 10) of the closed-chest, catheter-based method that we use for creating mitral regurgitation (3, 29). Of note, in contrast to the transient hemodynamic instability often seen after surgically created mitral regurgitation (29), this did not occur after surgically created tricuspid regurgitation. Seven normal dogs served as controls. After recovery, we maintained each operated dog on a standard canine diet for 3.5–4.0 yr. Two operated dogs experienced unobserved sudden death at the end of the study period. At final study, each remaining dog was lightly anesthetized with intravenous fentanyl-droperidol and inhaled nitrous oxide-oxygen, a combination having little effect on myocardial contractile function (29). To prevent the confounding influences of changing adrenergic tone on inotropic state and heart rate during estimations of contractility, measurements of ventricular function were made in a -blocked state, as validated by isoproterenol challenge (29), induced by a loading dose of esmolol (0.5 mg 䡠 kg⫺1 䡠 min⫺1 iv for 3 min) followed by a constant infusion of esmolol (0.3 mg 䡠 kg⫺1 䡠 min⫺1 iv). Sheaths for arterial and venous access were placed in the femoral region, and systemic arterial pressures were monitored. After measuring right-sided pressures with a Swan-Ganz catheter, we performed left and right ventriculography with the use of a pigtail catheter for the LV and a Nishiya catheter (22) for the RV. These procedures for evaluating ventricular function were based on those Length, m Width, m Control MYOCARDIAL FUNCTION IN TRICUSPID REGURGITATION H13 Fig. 2. Photomicrographs of freshly isolated RV cardiocytes from a control dog (top) and a dog with tricuspid regurgitation (bottom). The scale bar represents 25 m. severe RV volume overloading causing overt right heart failure was present in each of these dogs. Cardiocyte morphology. Cardiocyte dimensions were evaluated in terms of cellular length and width. As RESULTS Characteristics of experimental model. All of the dogs with tricuspid regurgitation had, on physical examination, a grade III–IV/VI pansystolic murmur at the lower left sternal border, with a readily palpable parasternal thrill. Right heart failure, as evidenced by marked peripheral edema and ascites, was prominent in all dogs. As shown in Table 1, RV systolic pressure was normal, as was aortic systolic pressure. Right ventriculography, shown in Fig. 1, demonstrated in each dog with tricuspid regurgitation complete and rapid opacification of the right atrium at end systole, and there was incomplete ejection of contrast material from the right atrium at end diastole. Thus isolated, Fig. 3. Display of sarcomere motion sampled at a frequency of 1 kHz during contractions of single cardiocytes. A: RV cells from a control dog (left) and from a dog with tricuspid regurgitation for 3.5 yr (right). B: left ventricular (LV) cells from a control dog (left) and from a dog with mitral regurgitation for 3 mo (right). Sarcomere mechanics were averaged for 10 contractions of each cardiocyte studied at 37°C, 2.5 mM Ca2⫹, and 0.25-Hz stimulation frequency. The data for the LV cells, taken from our previous study (see Ref. 29), were gathered with the same device under the same conditions. Downloaded from http://ajpheart.physiology.org/ by 10.220.33.5 on May 12, 2017 them by gravity. The Ca2⫹ concentration was gradually increased to 2.5 mM, after which the cells were kept for 1 h at 37°C in collagenase-free buffer before defining contractile function. Cardiocyte mechanics. Our methods for laser diffraction measurement of sarcomere motion in isolated cardiocytes have been described before (15, 29). Cells were added to 37°C, 2.5 mM Ca2⫹ buffer in a well affixed to a glass slide. Only single, rod-shaped cells with a resting sarcomere length ⱖ1.85 m and that contracted with each stimulus and were quiescent between stimuli were analyzed. Ten steady-state contractions during 0.25-Hz electrical stimulation were sampled and averaged to yield a final profile of sarcomere length and velocity versus time during contraction. Changes in sarcomere length were measured at a sampling rate of 1 kHz from movement of the first-order diffraction pattern cast by light from a substage helium-neon laser passing through the sarcomeres. Cardiocyte morphology. Two aliquots of isolated cardiocytes from each specimen were plated in separate dishes, and randomly selected cell images were captured on an inverted microscope at a magnification of ⫻400 by a frame grabber. The images were printed at a final magnification of ⫻1,100, and cell length and width were measured manually. Statistical analysis. The mean value and the standard error of the mean are shown for each group of data. Differences in selected measures were evaluated via an unpaired Student’s t-test, with a significant difference said to exist at the level specified in each case. H14 MYOCARDIAL FUNCTION IN TRICUSPID REGURGITATION given numerically in Table 2 and illustrated in Fig. 2, RV cardiocytes from the dogs with tricuspid regurgitation were significantly longer and wider than RV cardiocytes from control dogs. Both the numerical values from and the appearance of volume-overloaded hypertrophied RV cells here are strikingly similar to those found in our previous study (see Ref. 29; Table 4 and Fig. 3) of volume-overloaded hypertrophied LV cells from dogs with isolated, severe mitral regurgitation. Cardiocyte mechanics. Representative illustrations of sarcomere mechanics in cardiocytes from control and tricuspid regurgitation RVs are shown in Fig. 3. Because our intent in this study was to compare intrinsic myocardial contractile function in RV volume overloading caused by tricuspid regurgitation with that in LV volume overloading caused by mitral regurgitation, illustrative sarcomere mechanics from our study (29) of cardiocytes from control and mitral regurgitation LVs are also shown in Fig. 3. Summary data in Fig. 4 show that the extent and velocity of sarcomere shortening in RV cardiocytes from dogs with tricuspid regurgitation were only slightly decreased when compared with corresponding values for cells from control dogs, with no statistical difference; there was no significant difference between control versus tricuspid regurgitation cardiocytes in terms of initial sarcomere length (1.941 ⫾ 0.011 vs. 1.918 ⫾ 0.009 m), time to peak shortening (214 ⫾ 2 vs. 215 ⫾ 2 ms), peak relaxation velocity (3.90 ⫾ 0.14 vs. 3.63 ⫾ 0.17 m/s), or time to peak relaxation velocity (39 ⫾ 2 vs. 42 ⫾ 1 ms). However, as shown for comparison purposes in Fig. 4, LV cardiocytes from dogs with severe mitral regurgitation (29), albeit at a different temporal but at a similar pathophysiological point in the progression of heart failure, showed significant decrements both in the extent and in the velocity of sarcomere shortening. DISCUSSION The principal finding of this study is that the contractile function intrinsic to the RV of dogs with longstanding, severe RV volume overloading is normal. This stands in distinct contrast to our earlier studies of severe LV volume overloading, wherein intrinsic contractile function was depressed (19, 27, 29). This contrast is all the more striking when one considers that the dogs with severe mitral regurgitation were studied at 3–6 mo after the lesion was produced, whereas the dogs with severe tricuspid regurgitation were studied at 3.5–4.0 yr after the lesion was produced. Indeed, we would have preferred to have more dogs available here for final study, but the fact that contractile function was normal in tricuspid regurgitation gives us confidence in the validity of our principal finding. That is, experimental artifacts exaggerated by a low sample number might well have led to a false finding of abnor- Downloaded from http://ajpheart.physiology.org/ by 10.220.33.5 on May 12, 2017 Fig. 4. Summary of sarcomere dynamics in RV cardiocytes from 5 dogs with tricuspid regurgitation (A: Cross-hatched bars) versus those in RV cardiocytes from 7 control dogs (hatched bars). Also shown for comparison are summary data taken from our previous study (see Ref. 29) of sarcomere dynamics in LV cardiocytes from 10 dogs with mitral regurgitation (B: Cross-hatched bars) versus those in LV cardiocytes from 7 control dogs (hatched bars). Values are means ⫾ SE. Statistical comparisons were made by Student’s unpaired t-test between the control and experimental group within each category rather than between the two categories. *P ⬍ 0.05 for difference from the respective within-category control group. MYOCARDIAL FUNCTION IN TRICUSPID REGURGITATION cuspid than in mitral regurgitation. Thus the attenuated LV hypertrophic response to load in mitral regurgitation may lead by default to an early, sustained reliance on increases in heart rate and adrenergic tone, which we have shown to be clearly deleterious to intrinsic myocardial properties in mitral regurgitation (19, 27) and to intrinsic cardiac cellular properties in normal isolated cardiocytes (17). This difference between RV and LV volume overloading may also be related, at least speculatively, to the following additional factors. First, the initial hemodynamic burden caused by sudden and severe atrioventricular valvular incompetence may be greater when imposed on the high-systolic-pressure LV than it is when imposed on the low-systolic-pressure RV. Second, in the present study of tricuspid regurgitation, LV function was normal, such that there may have been less neurohumoral stimulation (12). The renin-angiotensin system and sympathetic nervous system have a clear role in the development of LV failure after systemic hemodynamic overloads (14), but these systems could be less important in isolated tricuspid regurgitation in the absence of LV dysfunction. Third, because LV contraction contributes to the generation of RV stroke work via the interventricular septum (13, 23), the normal interventricular septum in tricuspid regurgitation may contribute to the maintenance of overall RV function. Clinical experience demonstrates that RV volume overloading is well tolerated in the absence of pressure overloading superimposed by pulmonary hypertension (16, 20). Furthermore, experimental animal models of arterio-venous fistula (24, 28), atrio-ventricular blockade (21), and atrial septal defect (8) also demonstrate normal intrinsic RV function in RV volume overloading. In contrast, whereas chronic LV volume overloading in humans may be tolerated for years, LV dysfunction and heart failure often supervene eventually (4, 9, 11, 25, 26), quite possibly related to our finding of depressed intrinsic LV contractile function in this entity (29). Thus, whereas both RV and LV volume overloading may cause overt heart failure, the preserved intrinsic RV contractile function shown in this and in our earlier study (8) of RV volume overloading, and the exhausted intrinsic LV contractile function shown in our studies (3, 5, 19, 27, 29) of LV volume overloading, suggest that the etiology of this heart failure may be predominantly nonmyocardial in the former case and myocardial in the latter case. The authors thank Dr. Robert Bauman for preparing the dogs with tricuspid regurgitation as well as Gilberto DeFreyte and Mary Barnes for technical assistance. This study was supported by National Heart, Lung, and Blood Institute Grants HL-18468 and HL-48788 and by research funds from the Department of Veterans Affairs. REFERENCES 1. Bauman RP, Rembert JC, and Greenfield JC Jr. Myocardial blood flow in awake dogs with chronic tricuspid regurgitation. Basic Res Cardiol 93: 63–69, 1998. Downloaded from http://ajpheart.physiology.org/ by 10.220.33.5 on May 12, 2017 mal function, but artifactual contributions to a finding of normal function are much less likely. The distinction made evident through the striking difference between the present study of RV volume overloading by tricuspid regurgitation and the previous studies (19, 27, 29) of LV volume overloading by mitral regurgitation is that between muscle failure versus pump failure as the root cause of the congestive heart failure syndrome. In the present study of tricuspid regurgitation, all of the dogs had severe, clinically overt right-sided congestive heart failure, with ascites and loss of appetite. Indeed, two of the original operative cohort experienced sudden death, which triggered the final study of the remaining dogs. While it is likely that these dogs experienced a lethal arrythmia, because they were not being monitored electrocardiographically this cannot be known with certainty. But most significantly, the root cause of congestive heart failure in these dogs is shown here to be pump rather than muscle failure. In the previous study of mitral regurgitation, all of the dogs by 6 mo after the operation had clinically overt, rapidly progressive left-sided congestive heart failure that precluded longer-term study. But in contrast to the situation in the present study, the root cause of congestive heart failure in mitral regurgitation was shown to be muscle rather than pump failure. The principal value of this study, therefore, is the evidence provided that even with the prolonged and extreme degree of hemodynamic overloading imposed here, the cardiac hypertrophy that results is not necessarily maladaptive, in that normal cellular contractile function may be retained. That is, it is not solely the magnitude but equally the type of hemodynamic overloading that determines whether the cardiac hypertrophic response to any such challenge remains compensatory. Nor can the difference between the RV and LV functional response to volume overloading be attributed to intrinsic differences between RV and LV cardiocytes, because we have shown that the functional responses of cardiocytes from the two chambers to biventricular volume overloading is identical (28). Rather, the differing myocardial responses to these two volume overloads may well relate to the established role of hemodynamic load in regulating cardiac mass (6, 7). That is, load in the form of systolic afterload immediately after major atrioventricular valvular incompetence is imposed may be relatively better preserved in the lower pressure RV with tricuspid regurgitation than it is in the higher pressure LV with mitral regurgitation. The consequence of this loading difference in terms of stimulating cardiac hypertrophy may be aggravated by the fact that there is a diminished LV hypertrophic load response during mitral regurgitation to a given amount of stroke work input (5). Furthermore, because by Laplace’s law ventricular wall stress is related to the product of intraventricular pressure and ventricular radius and because RV chamber compliance is very high, an increase in ventricular radius and a subsequent increase in wall stress may induce a more effective hypertrophic response in tri- H15 H16 MYOCARDIAL FUNCTION IN TRICUSPID REGURGITATION 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. adult atrial septal defect. Preoperative and postoperative assessment and clinical implications. Am J Cardiol 47: 56–60, 1981. Mann DL, Kent RL, Parsons B, and Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85: 790–804, 1992. Mulieri LA, Leavitt BJ, Martin BJ, Haeberle JR, and Alpert NR. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation 88: 2700– 2704, 1993. Nagatsu M, Spinale FG, Koide M, Tagawa H, DeFreitas G, Cooper G, and Carabello BA. Bradycardia and the role of -blockade in the amelioration of left ventricular dysfunction. Circulation 101: 653–659, 2000. Nagel E, Stuber M, and Hess OM. Importance of the right ventricle in valvular heart disease. Eur Heart J 17: 829–836, 1996. Newman WH. Contractile state of hypertrophied left ventricle in long-standing volume overload. Am J Physiol Heart Circ Physiol 234: H88–H93, 1978. Nishiya Y, Imamura E, and Inoue Y. A new preshaped catheter for right ventriculography with minimal artificial tricuspid regurgitation. Ann Thorac Cardiovasc Surg 4: 214–216, 1998. Rigolin VH, Robiolio PA, Wilson JS, Harrison JK, and Bashore TM. The forgotten chamber: the importance of the right ventricle. Cathet Cardiovasc Diagn 35: 18–28, 1995. Ross J Jr and McCullagh WH. Nature of enhanced performance of the dilated left ventricle in the dog during chronic volume overloading. Circ Res 30: 549–556, 1972. Schuler G, Peterson KL, Johnson A, Francis G, Dennish G, Utley J, Daily PO, Ashburn W, and Ross J Jr. Temporal response of left ventricular performance to mitral valve surgery. Circulation 59: 1218–1231, 1979. Starling MR, Kirsh MM, Montgomery DG, and Gross MD. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 22: 239–250, 1993. Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper G, and Carabello BA. Effects of chronic -adrenergic blockade on the left ventricular and cardiocyte abnormalities in chronic canine mitral regurgitation. J Clin Invest 93: 2639–2648, 1994. Urabe Y, Hamada Y, Spinale FG, Carabello BA, Kent RL, Cooper G, and Mann DL. Cardiocyte contractile performance in experimental biventricular volume-overload hypertrophy. Am J Physiol Heart Circ Physiol 264: H1615–H1623, 1993. Urabe Y, Mann DL, Kent RL, Nakano K, Tomanek RJ, Carabello BA, and Cooper G. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res 70: 131–147, 1992. Downloaded from http://ajpheart.physiology.org/ by 10.220.33.5 on May 12, 2017 2. Bonz A, Vahl CF, and Hagl S. Contractile behaviour and intracellular calcium during afterloaded contraction in mitral valve disease. Thorac Cardiovasc Surg 45: 280–286, 1997. 3. Carabello BA, Nakano K, Corin W, Biederman R, and Spann JF Jr. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol Heart Circ Physiol 256: H974–H981, 1989. 4. Carabello BA, Nolan SP, and McGuire LB. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio. Circulation 64: 1212–1217, 1981. 5. Carabello BA, Zile MR, Tanaka R, and Cooper G. Left ventricular hypertrophy due to volume overload versus pressure overload. Am J Physiol Heart Circ Physiol 263: H1137–H1144, 1992. 6. Cooper G. Cardiocyte adaptation to chronically altered load. Annu Rev Physiol 49: 501–518, 1987. 7. Cooper G. Basic mechanisms of myocardial hypertrophy: a review of molecular mechanisms. Annu Rev Med 48: 13–23, 1997. 8. Cooper G, Puga FJ, Zujko KJ, Harrison CE, and Coleman HN. Normal myocardial function and energetics in volumeoverload hypertrophy in the cat. Circ Res 32: 140–148, 1973. 9. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM, and Krayenbuehl HP. The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation 76: 59– 67, 1987. 10. Dolber PC, Bauman RP, Rembert JC, and Greenfield JC Jr. Regional changes in myocyte structure in model of canine right atrial hypertrophy. Am J Physiol Heart Circ Physiol 267: H1279–H1287, 1994. 11. Eckberg DL, Gault JH, Bouchard RL, Karliner JS, and Ross J Jr. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation 47: 1252–1259, 1973. 12. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, and Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724–1729, 1990. 13. Hoffman D, Sisto D, Frater RW, and Nikolic SD. Left-toright ventricular interaction with a noncontracting right ventricle. J Thorac Cardiovasc Surg 107: 1496–1502, 1994. 14. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322: 100– 110, 1990. 15. Kent RL, Mann DL, Urabe Y, Hisano R, Hewett KW, Loughnane M, and Cooper G. Contractile function of isolated feline cardiocytes in response to viscous loading. Am J Physiol Heart Circ Physiol 257: H1717–H1727, 1989. 16. Liberthson RR, Boucher CA, Strauss HW, Dinsmore RE, McKusick KA, and Pohost GM. Right ventricular function in